Ocular Therapeutix OCUL Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ocular Therapeutix's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ocular Therapeutix's total liabilities & equity?
- Ocular Therapeutix (OCUL) reported total liabilities & equity of $732.53M in Q1 2026.
- How has Ocular Therapeutix's total liabilities & equity changed year-over-year?
- Ocular Therapeutix's total liabilities & equity increased by 80.5% year-over-year, from $405.92M to $732.53M.
- What is the long-term trend for Ocular Therapeutix's total liabilities & equity?
- Over 5 years (2020 to 2025), Ocular Therapeutix's total liabilities & equity has grown at a 25.3% compound annual growth rate (CAGR), from $261.86M to $808.06M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.